Additionally, although significant adverse gatherings rates had been equivalent between teams, people receiving ibrutinib experienced a greater incidence of some precise adverse situations including bleeding, hypertension and atrial fibrillation. Di sini, BP77 berkomitmen untuk memberikan pengala